NCT07412652

Brief Summary

This randomized controlled clinical trial compares ultrasound-guided local ozone injection, extracorporeal shock wave therapy, and conventional conservative treatment in patients with chronic Achilles tendinopathy. The study focuses on changes in pain, functional outcomes, and overall clinical improvement during the follow-up period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 2, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 2, 2026

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2026

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

February 9, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 17, 2026

Completed
Last Updated

February 17, 2026

Status Verified

January 1, 2026

Enrollment Period

8 months

First QC Date

February 9, 2026

Last Update Submit

February 9, 2026

Conditions

Keywords

Achilles tendinopathy, extracorporeal shock wave therapy,physical therapy modality

Outcome Measures

Primary Outcomes (2)

  • Pain intensity (Visual Analog Scale, VAS)

    Pain intensity is assessed using the Visual Analog Scale (VAS).

    Baseline, post-treatment, and 12 weeks after treatment

  • Pain intensity assessed by Visual Analog Scale (VAS)

    The Visual Analog Scale (VAS) is used to assess subjective pain intensity related to Achilles tendon pain.

    Baseline, post-treatment, and 12-week follow-up

Secondary Outcomes (2)

  • Victorian Institute of Sports Assessment-Achilles (VISA-A) score

    Baseline, post-treatment, and 12-week follow-up

  • Roles and Maudsley Score (RMS)

    Baseline, post-treatment, and 12-week follow-up

Study Arms (3)

Ultrasound-Guided Ozone Injection

ACTIVE COMPARATOR

Participants receive ultrasound-guided local ozone injection administered to the affected Achilles tendon according to a standardized treatment protocol.

Other: Ultrasound-Guided Local Ozone Injection

Extracorporeal Shock Wave Therapy (ESWT)

ACTIVE COMPARATOR

Participants receive extracorporeal shock wave therapy applied to the affected Achilles tendon according to a standardized treatment protocol.

Device: Extracorporeal Shock Wave Therapy (ESWT)

Conventional Conservative Treatment

OTHER

Participants receive conventional conservative treatment consisting of a standardized exercise program and activity modification.

Other: Conventional Conservative Treatment

Interventions

Ultrasound-guided local ozone injection is administered to the peritendinous region of the affected Achilles tendon under sterile conditions using a high-frequency linear transducer, according to a standardized treatment protocol.

Ultrasound-Guided Ozone Injection

Extracorporeal shock wave therapy is applied to the affected Achilles tendon according to a standardized treatment protocol.

Extracorporeal Shock Wave Therapy (ESWT)

Conventional conservative treatment consists of a standardized exercise program and activity modification.

Conventional Conservative Treatment

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 to 65 years.
  • Patients with a diagnosis of Achilles tendinopathy confirmed by ultrasonography or magnetic resonance imaging (MRI).
  • Patients with persistent symptoms despite completion of conservative treatment.
  • Volunteers who agree to participate in the study.

You may not qualify if:

  • Patients with symptoms lasting less than 12 weeks.
  • Presence of contraindications to extracorporeal shock wave therapy (ESWT), including pregnancy; history of thrombosis; use of anticoagulant medications; coagulation disorders such as hemophilia; systemic conditions; or localized conditions at the treatment site such as active infection or malignant tumors.
  • Presence of contraindications to local ozone injection, including pregnancy; glucose-6-phosphate dehydrogenase (G6PD) deficiency; favism; uncontrolled hyperthyroidism; thrombocytopenia; severe cardiovascular conditions; and use of angiotensin-converting enzyme (ACE) inhibitors.
  • History of neurological disease, muscle disease, or peripheral vascular disease.
  • Presence of congenital or acquired deformities of the knee and/or ankle.
  • Receipt of physical therapy modalities applied to the Achilles tendon within the last 6 weeks.
  • Receipt of any therapeutic injection to the Achilles tendon within the last 12 weeks.
  • History of direct trauma to the symptomatic Achilles tendon or Achilles tendon rupture.
  • History of surgical treatment involving the Achilles tendon or ankle for any reason.
  • History of foot or ankle dislocation or fracture within the past 1 year.
  • Presence of systemic inflammatory diseases that may affect tendon structure, such as ankylosing spondylitis, reactive arthritis, or psoriatic arthritis.
  • Patients with isolated insertional Achilles tendinopathy without tenderness in the mid-portion of the tendon

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital - Physical Medicine and Rehabilitation Hospital

Ankara, Cankaya, 06800, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Extracorporeal Shockwave Therapy

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors are blinded to group allocation. No other parties are masked in this study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study consists of three parallel groups: Group 1 receives ultrasound-guided local ozone injection, Group 2 receives extracorporeal shock wave therapy (ESWT), Group 3 receives conventional conservative treatment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
medical doctor

Study Record Dates

First Submitted

February 9, 2026

First Posted

February 17, 2026

Study Start

May 2, 2025

Primary Completion

January 2, 2026

Study Completion

January 15, 2026

Last Updated

February 17, 2026

Record last verified: 2026-01

Locations